# FDA 483 - MiMedx Group, Inc. - March 02, 2023

Source: https://www.keypedia.com/records/483/mimedx-group-inc/a54dca3f-d0f8-460f-b292-d575349487d3

> FDA 483 for MiMedx Group, Inc. on March 02, 2023. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: MiMedx Group, Inc.
- Inspection Date: 2023-03-02
- Product Type: biologics
- Office Name: Atlanta District Office
- Summary: MiMedx Group, Inc. in Marietta, GA, was inspected by the FDA from February 22 to March 2, 2023. The inspection revealed a significant issue with the control over labeling operations, specifically concerning the staging and reconciliation of packaging materials for Axiofill placental collagen matrix products. This indicates a lack of adequate procedures to ensure proper identification and accountability of labeling materials.

## Related Documents

- [483 - 2016-02-04](https://www.keypedia.com/records/483/mimedx-group-inc/7cdc93e3-1e3c-4b2c-b928-f477d33f7ab6)
- [483 - 2019-12-12](https://www.keypedia.com/records/483/mimedx-group-inc/48b61282-fda8-4f55-be73-da526c3212d7)

## Related Officers

- [Cody D. Rickman](https://www.keypedia.com/people/cody-d-rickman/54deec25-dc65-4402-991a-ad5589bad78b)
- [Marla A. Cassidy](https://www.keypedia.com/people/marla-a-cassidy/d2859ca5-e77b-4385-9a96-4c785f3ac4c6)
- [Christopher J. Adams](https://www.keypedia.com/people/christopher-j-adams/f7010846-7fd1-4ee8-901a-1015656fea0a)

Company: https://www.keypedia.com/companies/mimedx-group-inc/5cdb415e-75d0-406f-8a40-b5179024098f

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7